Sonok Anti-aging Technology
SoSDT technology originated from sonodynamic tumor treatment, and based on long-term clinical practice, it has been expanded in two directions to form a systemic medical platform of "cancer prevention + precise anti-aging".
The medical community generally believes that there is no sudden cancer, only cancer that is suddenly discovered (ie, malignant tumor). The occurrence of cancer usually goes through a long-term insidious process, including stages such as chronic micro-inflammation, metabolic abnormalities, decreased immune surveillance function, and local microenvironmental disorder. However, traditional medical methods mainly focus on "visible lesions" and are difficult to identify abnormal cell changes in the subclinical stage years before the occurrence of cancer, resulting in a passive delay in the intervention window.
SoSDT uses sonosensitizers to preferentially target tiny abnormal cells, as well as non-focused ultrasound-induced ICD and immune reconstitution mechanisms, allowing the immune system to intervene early at the risk stage of cancer to achieve the removal of potentially abnormal cells and the establishment of long-term immune surveillance, thus providing an implementable and repeatable technical path for cancer prevention.
SoSDT’s medical innovations
SoSDT passed:
Sound sensitizer targets tiny abnormal cells
Low frequency non-focused ultrasound activation → ROS → ICD (immunogenic cell death)
Start immune reconstruction mechanism in advance
Implemented:
A cancer prevention pathway that intervenes “before the disease becomes visible.”
This is currently one of the most "implementable and implementable" pre-cancer intervention technology solutions in the world.
